Sensus Healthcare (SRTS)
Supplies superficial-radiation systems for non-melanoma skin cancer and keloid treatment.
$3.08
vs last close−0.02 (−0.65%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 22.16% | 3.65M shares | |
|---|---|---|---|
| 41 holders · as of Jun 30, 2026 | |||
| Insiders | 18.90% | 3.11M shares | |
| 9 holders · as of Aug 31, 2026 | |||
| Other | 58.94% | 9.70M shares | |
| remainder | |||
16.46M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
41 holders · 3.65M shares · 4 new positions · 13 increased · 13 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Pacific Ridge Capital Partners, LLC | 789.7K | 4.80% | −6.4K | Aug 12, 2026 |
| Vanguard Capital Management LLC | 660.4K | 4.01% | +12.2K | Aug 13, 2026 |
| Dimensional Fund Advisors LP | 316.1K | 1.92% | −71.3K | Aug 11, 2026 |
| Divisadero Street Capital Management, LP | 278.5K | 1.69% | −7.6K | Aug 14, 2026 |
| Renaissance Technologies LLC | 242.3K | 1.47% | −9.9K | Aug 13, 2026 |
| Geode Capital Management, LLC | 154.2K | 0.94% | −11.4K | Aug 12, 2026 |
| UBS Group AG | 152.6K | 0.93% | −20.3K | Aug 13, 2026 |
| Sachetta, LLC | 152.0K | 0.92% | +1.5K | Jul 15, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Edwin L. Solot, Jr. | 7.60% | 1.25M | 13G | Feb 7, 2025 |
| Joseph C. Sardano | 7.10% | 1.18M | 13G | May 22, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 31, 2026 | Eric Sachettadirector | Purchase | 27,304 | $3.54 | 294,784 |
| Aug 28, 2026 | Eric Sachettadirector | Purchase | 37,537 | $3.44 | 267,480 |
| Aug 27, 2026 | Eric Sachettadirector | Purchase | 10,925 | $3.18 | 229,943 |
| Aug 26, 2026 | Eric Sachettadirector | Purchase | 9,708 | $3.29 | 219,018 |
| Aug 24, 2026 | Eric Sachettadirector | Purchase | 34,697 | $3.25 | 209,310 |
| Aug 20, 2026 | Joseph C. Sardanodirector, officer: CHIEF EXECUTIVE OFFICER | Purchase | 20,000 | $3.02 | 1,220,293 |
| Aug 21, 2026 | Eric Sachettadirector | Purchase | 7,000 | $3.25 | 174,613 |
| Aug 20, 2026 | Eric Sachettadirector | Purchase | 24,000 | $3.13 | 167,613 |
| May 12, 2026 | Eric Sachettadirector | Purchase | 1,500 | $3.34 | 143,613 |
| Feb 24, 2026 | Eric Sachettadirector | Purchase | 2,000 | $3.81 | 142,113 |
House and Senate disclosures
Not reported.